MedTrace Logo

Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network

NCT04937361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14607

Last updated 2026-05-06

No results posted yet for this study

Summary

Survey on the prevalence of MDRO to monitor the import of MDRO from the community. Rectal swabs will be taken and cultivated. Survey on community-onset and nosocomial bloodstream infections will be documented and strains will be isolated. For each BSI a clinical data set will be obtained (e.g. patient age, gender, date of hospitalization, antibiotic therapy). Genetic analysis of MDRO from the prevalence and BSI study. In a subset of patients the microbiome-resistome interactome will be analysed in more detail. Furthermore, the impact of infection control measures due to the Covid-19 pandemic on nosocomial BSI will be investigated.

Conditions

  • MDRO

Interventions

OTHER

rectal swab

collection of rectal swabs

Sponsors & Collaborators

  • University Hospital of Berlin

    collaborator OTHER

  • University Hospital of Cologne

    collaborator OTHER

  • University Hospital Freiburg

    collaborator OTHER

  • University of Giessen

    collaborator OTHER

  • University Hospital Tuebingen

    collaborator OTHER

  • University of Luebeck

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-23
Primary Completion
2025-02-28
Completion
2025-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937361 on ClinicalTrials.gov